Drugs / CLS001
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02028286 | Jan → Mar 2014 | rosacea | Maruho Co., Ltd. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02066545 | Apr → Nov 2014 | acne | Maruho Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CLS001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02066545 ↗ |
| Route | Topical | “once-daily CLS001 Topical Gel” NCT02028286 ↗ |